Research graph
References from Diagnostic performance of third-generation sequencing for tuberculous pericarditis: a systematic review and meta-analysis protocol. Local targets link to admitted publications; unresolved targets remain external evidence.
Tuberculosis: An Ongoing Global Threat
10.1007/978-3-031-96883-9_1 · 2026 · External reference
10.1016/j.ijtb.2020.02.005
10.1016/j.ijtb.2020.02.005 · External reference
Tuberculous Pericarditis—Own Experiences and Recent Recommendations
10.3390/diagnostics12030619 · 2022 · External reference
10.1093/qjmed/hcl123
10.1093/qjmed/hcl123 · External reference
Diagnosis and Management of Tuberculous Pericarditis: What Is New?
10.1007/s11886-020-1254-1 · 2020 · External reference
Tuberculous pericardial disease: a focused update on diagnosis, therapy and prevention of complications
10.21037/cdt.2019.09.20 · 2020 · External reference
Diagnosis of Tuberculous Pericarditis in Zhejiang, China: A Diagnostic Prediction Model Based on LASSO Logistic Regression
10.2147/jir.s504183 · 2025 · External reference
The Efficiency of TB LAM Antigen Test to Xpert MTB/RIF Ultra Test for the Diagnosis of Tuberculous Pericarditis Using Pericardial Fluid Samples
10.3390/pathogens12091175 · 2023 · External reference
Diagnostic accuracy of the Xpert MTB/RIF assay for tuberculous pericarditis: A systematic review and meta-analysis
10.1371/journal.pone.0257220 · 2021 · External reference
Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies
10.1128/jcm.00815-24 · 2024 · External reference
Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis
10.1016/s2666-5247(22)00301-9 · 2023 · External reference
High-throughput nanopore targeted sequencing for efficient drug resistance assay of Mycobacterium tuberculosis
10.3389/fmicb.2024.1331656 · 2024 · External reference
Nanopore sequencing for precise detection of Mycobacterium tuberculosis and drug resistance: a retrospective multicenter study in China
10.1128/jcm.01813-24 · 2025 · External reference
Nanopore-based targeted next-generation sequencing of tissue samples for tuberculosis diagnosis
10.3389/fmicb.2024.1403619 · 2024 · External reference
Diagnostic value of third-generation nanopore sequencing in extrapulmonary tuberculosis
10.3389/fcimb.2024.1432446 · 2024 · External reference
Nanopore sequencing for smear-negative pulmonary tuberculosis-a multicentre prospective study in China
10.1186/s12941-024-00714-2 · 2024 · External reference
Evaluation of Nanopore Sequencing for Diagnosing Pulmonary Tuberculosis Using Negative Smear Clinical Specimens
10.2147/idr.s442229 · 2024 · External reference
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2016 · External reference
Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist
10.1136/bmj.m2632 · 2020 · External reference
10.1059/0003-4819-155-8-201110180-00009
10.1059/0003-4819-155-8-201110180-00009 · External reference
